Primary FDA-Approved Indications
Used for ulcers, reflux esophagitis, and mucositis adjunctive therapy.
Peptic ulcer disease
FDA ApprovedChildrenClinical trials
Evidence Sources
()
Reflux esophagitis (adjunct)
FDA ApprovedChildrenClinical experience